Sheila Wilson, M.B.A.

Chief Operating Officer

Ms. Wilson has been serving as our Chief Operating Officer since February 2019, having served previously as Senior Vice President, Clinical Development Operations, from February 2018 to February 2019, and as Vice President, Clinical Operations from October 2016 to February 2018. Prior to joining Proteostasis Therapeutics, Ms. Wilson served as Vice President, Global Operations at Synta Pharmaceuticals in Lexington, Massachusetts. From July 2014 to February 2015, Ms. Wilson headed Sheila Wilson Consulting, where she developed operational governance strategies, clinical quality consultations, and standard operating procedures (SOPs) for various pharmaceutical companies. Ms. Wilson was Vice President, Global Clinical Operations at Vertex Pharmaceuticals, Inc., in Cambridge, Massachusetts, from March 2010 to November 2013, where she led Global Clinical Operations, supporting Phases I through IV clinical programs. Ms. Wilson also served as Senior Vice President, Operations and Quality Assurance at ePharmaSolutions in Conshohocken, Pennsylvania, from January 2008 to March 2010, where she was responsible for the creation and administration of internal policies and SOPs. Prior to that, she served as Vice President, US Medical Operations at Pfizer Pharmaceuticals, Inc., from 2005 to 2007.